We upgraded AAFP.org security on Dec. 7.
Account holders must create a new password. Previous passwords will no longer work.

brand logo

Am Fam Physician. 2025;112(6):629-637

This clinical content conforms to AAFP criteria for CME.

Author disclosure: No relevant financial relationships.

Cancer screening guidelines for older adults are increasingly recommending individualized decision-making rather than relying on age cutoffs. This is in large part due to the individual complexity of aging, such as functional differences, risks of diagnostic procedures, remaining life expectancy, perceived quality of life, and goals of care. The US Preventive Services Task Force (USPSTF) recommends screening for breast cancer until 74 years of age, whereas the American Cancer Society suggests screening as long as the patient is in good health or has a life expectancy of at least 10 years. The USPSTF recommends that men 55 to 69 years of age discuss the potential benefits and harms of prostate-specific antigen screening with their doctor before making an individual decision; for men 70 years and older, the USPSTF and the American Urological Association do not recommend routine screening. Most guidelines recommend that cervical cancer screening should stop at 65 years of age in patients who have adequate prior screening results and do not have high risk. The USPSTF and the American Cancer Society recommend routine colorectal cancer screening until 75 years of age, after which individualized screening can occur based on shared decision-making until 85 years of age. Guidelines recommend lung cancer screening for patients who are 50 to 80 years of age, have at least a 20-pack-year smoking history, and are able and willing to have curative surgery.

For many patients, cancer screening can prevent or improve illness, but it may also cause harms.1 However, most randomized controlled trials of cancer screening tests have not included adults older than 75 years.2,3 It is not always clear whether screening for cancer in older adults leads to net benefit (improved quantity or quality of life), and it may cause more harm in some patients.1 As a result, the screening guidelines of many leading medical societies incorporate individualized decision-making rather than relying on age cutoffs. When discussing cancer screening with older adults, clinicians should consider medical comorbidities, functional status, values and preferences, remaining life expectancy, and goals of care.4

Already a member/subscriber?  Log In

Subscribe

From $180
  • Immediate, unlimited access to all AFP content
  • More than 125 CME credits/year
  • AAFP app access
  • Print delivery available
Subscribe

Issue Access

$59.95
  • Immediate, unlimited access to this issue's content
  • CME credits
  • AAFP app access
  • Print delivery available

Article Only

$34.95
  • Immediate, unlimited access to just this article
  • CME credits
  • AAFP app access
  • Print delivery available
Interested in AAFP membership?  Learn More

Continue Reading

More in AFP

Copyright © 2025 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.